Trials / Completed
CompletedNCT00171964
Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions
Evaluation of the Efficacy and Tolerability of Zoledronic Acid in Combination With Radiotherapy in Patients With Advanced Osteolytic Bone Lesions
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 75 (actual)
- Sponsor
- Novartis Pharmaceuticals · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
It is the aim of this multicentric clinical study to assess the efficacy and tolerability of zoledronic acid in combination with radiotherapy in patients with advanced osteolytic bone lesions in terms of the reduction of pain and analgesic consumption.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Zoledronic acid in combination with therapy |
Timeline
- Start date
- 2002-05-01
- Primary completion
- 2008-12-01
- Completion
- 2008-12-01
- First posted
- 2005-09-15
- Last updated
- 2017-06-01
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT00171964. Inclusion in this directory is not an endorsement.